Viagra MDL Judge Rejects Plaintiff Expert Testimony Under Daubert
A detailed analysis (with rejoicing) from Drug and Device Law. The opinion details deficiencies in the plaintiff expert’s previously peer-reviewed and published study.
For a past article of mine that set forth problems in the main study underlying the opinions of plaintiffs’ experts in the phenylpropanolamine (PPA) litigation, see here.
BGS